Neogen Lowers FY2024 Adjusted EBITDA Guidance To $210M-$215M Vs. Prior Guidance Of $230M-$240M
Portfolio Pulse from Benzinga Newsdesk
Neogen has revised its FY2024 Adjusted EBITDA guidance downwards to $210M-$215M from the previously projected range of $230M-$240M.
April 09, 2024 | 11:09 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Neogen has lowered its FY2024 Adjusted EBITDA guidance, indicating potential challenges or lower-than-expected performance.
A downward revision in earnings guidance often leads to negative investor sentiment as it suggests potential operational challenges or lower-than-expected financial performance. This can result in a short-term decrease in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100